Navigation Links
Tests to catch the makers of dangerous 'legal high' designer drugs
Date:10/13/2011

Urgently needed tests which could help identify the manufacturers of designer 'legal high' drugs are being developed in research led at the University of Strathclyde in Glasgow.

The drugs, known by names such as 'ivory wave' and NRG-1" and sold labelled as bath salts, plant food and incense, mimic the effects of illegal drugs such as amphetamine, cocaine and ecstasy. Although these so-called 'designer drugs' can be dangerous, many have not yet been made illegal and are difficult to detect with current drug tests.

A means of potentially tracing the source of the raw materials, and consequently providing information as to who is making the 'bath salts,' is being developed by scientists at Strathclyde and The James Hutton Institute.

The bath salts drug can cause euphoria, paranoia, anxiety and hallucinations. It often contains mephedrone, a synthetic compound structurally related to methcathinone, which is found in Khat - a plant which, like mephedrone itself, is illegal in many countries.

The bath salts drug is labelled as being not for human consumption and is not illegal in the UK but its import has been banned. The term 'bath salts' is used by those who sell the drug as a way of circumventing legislation when supplying it.

The researchers developing tests for the drug are using a technique known as isotope ratio mass spectrometry (IRMS) to reveal the course of a drug's manufacture.

The research is being carried out by Dr Oliver Sutcliffe, at the Strathclyde Institute of Pharmacy and Biomedical Sciences, and Professor Niamh Nic Daeid and Dr Katy Savage at the Centre for Forensic Science in the Department of Pure and Applied Chemistry, in collaboration with Dr Wolfram Meier-Augenstein at The James Hutton Institute.

Dr Sutcliffe said: "The legal status of designer drugs varies around the world but they present many dangers to users and these are borne out by the Home Office's decision to ban the import of 'bath salts.'

"The new method we have used has enabled us to work backwards and trace the substances back to their starting materials. IRMS measures the relative amounts of an element's different forms- it is successful because these relative amounts are transferred like a fingerprint through the synthesis of the drug."


'/>"/>
Contact: Corporate Comms
corporatecomms@strath.ac.uk
44-014-154-82370
University of Strathclyde
Source:Eurekalert  

Related medicine news :

1. Direct-to-Consumer Gene Tests Cause Little Anxiety: Study
2. Blood tests may hold clues to pace of Alzheimers disease progression
3. New research shows $6.7 billion spent on unnecessary tests and treatments in one year
4. Annual Pap Tests Often Ordered But Unneeded: Study
5. Many Heart Patients Anemic After Too Many Blood Tests in Hospital
6. Frequent Tests Help Track Progression of Glaucoma, Study Finds
7. Abnormal liver tests associated with increased death rates in people over 75
8. Successful lab tests on a potential vaccine for heroin addiction
9. False negative tests in breast cancer may lead to wrong drug choice
10. Noninvasive liver tests may predict hepatitis C patient survival
11. Validity of Baseline Concussion Tests Questioned
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tests to catch the makers of dangerous 'legal high' designer drugs
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: